Neuraminidase inhibitors: the story behind the Cochrane review
MetadataShow full item record
Although billions have been spent on oseltamivir in the face of pandemic influenza, the team updating the Cochrane review of neuraminidase inhibitors in healthy adults found that the public evidence base for this global public health drug was fragmented and inconsistent. Peter Doshi tells the story
DepartmentMassachusetts Institute of Technology. Program in History, Anthropology, and Science, Technology, and Society
British Medical Journal
British Medical Association
Doshi, Peter. “Neuraminidase inhibitors--the story behind the Cochrane review.” BMJ 339.dec07_2 (2009): b5164.
Final published version